Corinne H.
- Country
- France
- Department
- #5006: Unité Hémopathies Lymphoïdes
Research Overview
- Efficacy and Safety Evaluation of Glofitamab with Gemcitabine and Oxaliplatin Versus Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Evaluation of Odronextamab's Anti-Tumor Efficacy and Safety in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Patients
- Evaluation of Glofitamab Combined with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in ctDNA High-Risk Untreated Diffuse Large B-Cell Lymphoma
Data & Insights
Has run more than one trial at 152 of 301 partner sites.
Specializations
Primary Lymphoma Research
This investigator specializes in treating various forms of B-cell lymphomas, with particular emphasis on diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma. Their research encompasses both newly diagnosed cases and relapsed/refractory disease states.
- Aggressive B-cell lymphomas
- Indolent lymphoma variants
- MALT lymphoma management
Therapeutic Approaches
The investigator focuses on innovative combination therapies including targeted antibody treatments and novel therapeutic agents. Their work involves evaluating new treatment protocols with established regimens like R-CHOP and exploring emerging therapeutic combinations.
- Immunotherapy combinations
- Novel agent development
- Maintenance therapy strategies
Treatment Innovation
Their research encompasses personalized medicine approaches in lymphoma treatment, including the evaluation of circulating tumor DNA for risk assessment and the development of targeted therapeutic strategies for specific patient populations.
- Biomarker-driven therapy
- Risk-adapted treatment
- Progressive disease management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.